Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabari Vallath
Observed name:
Vallath, Sabari
Observed institutions:
AstraZeneca (United Kingdom),
Biogen (United States),
Guy's Hospital,
Queen Mary University of London,
Cancer Research UK,
Southampton General Hospital,
Ninewells Hospital,
Nottingham City Hospital,
Barts Cancer Institute,
University College London
show all 10
OpenAlex ID:
A5111971024
Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
2014
·
Kate M. Moore
, Gareth J. Thomas
, et al.
·
JNCI Journal of the National Cancer Institute
·
144
PDF
Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities
2014
·
Sabari Vallath
, Robert E. Hynds
, et al.
·
European Respiratory Journal
·
137
PDF
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy
2019
·
Claire S Reader
, Sabari Vallath
, et al.
·
The Journal of Pathology
·
116
PDF
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
2017
·
Lynsey M. Whilding
, Ana C. Parente-Pereira
, et al.
·
Molecular Therapy
·
81
PDF
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
2017
·
Lynsey M. Whilding
, Ana C. Parente-Pereira
, et al.
·
Molecular Therapy
·
75
PDF
In Vivo Retargeting of Adenovirus Type 5 to αvβ6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake following Systemic Delivery
2009
·
Lynda Coughlan
, Sabari Vallath
, et al.
·
Journal of Virology
·
62
CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity
2016
·
Sabari Vallath
, Elizabeth K. Sage
, et al.
·
Scientific Reports
·
41
PDF
Combined Fiber Modifications Both to Target α v β 6 and Detarget the Coxsackievirus–Adenovirus Receptor Improve Virus Toxicity Profiles In Vivo but Fail to Improve Antitumoral Efficacy Relative to Adenovirus Serotype 5
2012
·
Lynda Coughlan
, Sabari Vallath
, et al.
·
Human Gene Therapy
·
40
PDF
Biological and clinical implications of nicastrin expression in invasive breast cancer
2010
·
Aleksandra Filipović
, Julian Hendrik Gronau
, et al.
·
Breast Cancer Research and Treatment
·
34
The integrin αvβ6: a novel target for CAR T-cell immunotherapy?
2016
·
Lynsey M. Whilding
, Sabari Vallath
, et al.
·
Biochemical Society Transactions
·
25
Two-dimensional heteronuclear saturation transfer difference NMR reveals detailed integrin αvβ6 protein–peptide interactions
2010
·
Jane L. Wagstaff
, Sabari Vallath
, et al.
·
Chemical Communications
·
22
Abstract B046: Therapeutic targeting of integrin αvβ6 in high-risk breast cancer
2013
·
Kate M. Moore
, Gareth J. Thomas
, et al.
·
Molecular Cancer Research
·
3
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
2026
·
Whilding, Lynsey M.
, Parente-Pereira, Ana C.
, et al.
·
PubMed Central
Abstract B53: The integrin αvβ6 is a promising therapeutic target for treating PDAC
2016
·
Sabari Vallath
, Claire Reader
, et al.
·
Cancer Research
Cadm1 regulates airway stem cell growth and differentiation via modulation of Stat3 activity
2016
·
Pooja Seedhar
, Elizabeth K Sage
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract B129: Chimeric antigen receptor T-cells targeting the αvβ6 integrin demonstrate potent antitumor activity in multiple solid tumors
2016
·
Lynsey May Whilding
, Ana C. Parente-Pereira
, et al.
·
Cancer Immunology Research
Abstract B87: Cell lines generated from PDAC transgenic mice reveal integrin αvβ6 modifies the invasive phenotype of pancreatic cancer
2015
·
Claire S. Reader
, Sabari Vallath
, et al.
·
Cancer Research
Abstract B42: Toward targeting integrin αvβ6 for the therapy of pancreatic cancer.
2012
·
Sabari Vallath
, Emaunela Gadaletta
, et al.
Show more works
View as search
Works count:
20
Citation count:
780
H-index:
11
I10-index:
11
Year
Topic
Type